Summit Capital Management’s MiMedx Group MDXG Stock Holding History

Summit Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.18M	Sell	478,145 -5,309	-1%	-$44.1K	1.89%	20
2015 Q4	$4.53M	Buy	483,454 +124,804	+35%	+$1.08M	1.83%	17
2015 Q3	$3.46M	Sell	358,650 -6,550	-2%	-$69.1K	1.69%	21
2015 Q2	$4.23M	Buy	365,200 +345,200	+1,726%	+$3.55M	1.81%	18
2015 Q1	$208K	Buy	+20,000	New	+$187K	0.08%	62
2014 Q4	–	Sell	-452,996	Closed	-$3.23M	–	68
2014 Q3	$3.23M	Buy	452,996 +150	+0%	+$1.05K	1.14%	32
2014 Q2	$3.21M	Buy	452,846 +286,800	+173%	+$1.68M	1.15%	31
2014 Q1	$1.02M	Buy	+166,046	New	+$1.22M	0.36%	42
2013 Q4	–	Sell	-414,476	Closed	-$1.73M	–	70
2013 Q3	$1.73M	Buy	+414,476	New	+$2.28M	0.82%	31

Other funds holding MDXG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Capital Management's MDXG Position: Q1 2016 in Review

Summit Capital Management reduced its MiMedx Group (MDXG) stake by 1.1% in Q1 2016, selling an estimated $44.1K and leaving 478,145 shares worth $4.18M. The position accounts for 1.89% of the portfolio, ranked #20.

Summit Capital Management first reported a position in MDXG in Q3 2013 and has held it in 9 quarters since. The position peaked at $4.53M in Q4 2015. 188 funds tracked by Wall St. Rank hold MDXG as of Q1 2016.

Summit Capital Management held 478,145 shares of MiMedx Group worth $4.18M as of Q1 2016.
Summit Capital Management sold 5,309 MiMedx Group shares in Q1 2016, an estimated $44.1K.
MiMedx Group made up 1.89% of Summit Capital Management's portfolio in Q1 2016, its #20 holding.
Summit Capital Management first reported a position in MiMedx Group in Q3 2013 and has held it in 9 quarters since.
Summit Capital Management's MiMedx Group position peaked at $4.53M in Q4 2015.
188 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2016.

Based on Summit Capital Management's 13F filing for Q1 2016, filed 11 May 2016.